tiprankstipranks
Provectus Pharmaceuticals (PVCT)
OTHER OTC:PVCT
US Market
PVCT
Provectus Pharmaceuticals
RESEARCH TOOLSreports

Provectus Pharmaceuticals (PVCT) Financial Statements

Compare
80 Followers

Provectus Pharmaceuticals Financial Overview

Provectus Pharmaceuticals's market cap is currently $20.88M. The company's EPS TTM is $-0.011; its P/E ratio is -4.33; Provectus Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 336.11K$ 617.14K$ 557.71K$ 989.04K$ 0.00
Gross Profit$ 334.25K$ 609.98K$ -1.14M$ 925.26K$ -94.12K
Operating Income$ -4.84M$ -3.95M$ -2.90M$ -3.43M$ -4.67M
EBITDA$ -4.84M$ -4.53M$ -2.89M$ -3.36M$ -4.62M
Net Income$ -5.43M$ -4.73M$ -3.10M$ -3.55M$ -5.54M
Balance Sheet
Cash & Short-Term Investments$ 251.29K$ 307.44K$ 76.58K$ 21.61K$ 682.98K
Total Assets$ 697.50K$ 1.01M$ 1.45M$ 2.04M$ 3.51M
Total Debt$ 4.72M$ 3.18M$ 3.03M$ 2.23M$ 1.74M
Net Debt$ 4.47M$ 2.88M$ 2.95M$ 2.21M$ 1.06M
Total Liabilities$ 7.00M$ 6.98M$ 9.04M$ 8.27M$ 7.70M
Stockholders' Equity$ -6.30M$ -5.96M$ -7.59M$ -6.23M$ -4.19M
Cash Flow
Free Cash Flow$ -3.33M$ -3.28M$ -2.57M$ -3.04M$ -1.01M
Operating Cash Flow$ -3.33M$ -3.28M$ -2.57M$ -3.04M$ -1.01M
Investing Cash Flow$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Financing Cash Flow$ 3.09M$ 2.75M$ 2.19M$ 1.37M$ 4.02M
Currency in USD

Provectus Pharmaceuticals Earnings and Revenue History

Income Statement >

Provectus Pharmaceuticals Debt to Assets

Balance Sheet >

Provectus Pharmaceuticals Cash Flow

Cash Flow >

Provectus Pharmaceuticals Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
Earnings >